`
`U.S. Patent No. 9,220,631
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`REGENERON PHARMACEUTICALS,INC.,
`Petitioner
`
`V.
`
`NOVARTIS PHARMAAG,
`NOVARTIS TECHNOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owners
`
`Case IPR2021-00816
`Patent 9,220,631
`
`PATENT OWNER NOVARTIS TECHNOLOGY LLC’S
`UPDATED POWER OF ATTORNEY
`
`
`
`US. Patent No. 9,220,631
`
`Pursuant to 37 C.F.R. § 42.10(b), Patent Owner, Novartis Technology
`
`LLC,hereby appoints Allen & Overy LLP and Goodwin Procter LLP and the
`
`following practitioners as its attorneys to transactall business in the United
`
`States Patent & Trademark Office associated with the above-captioned inter
`
`partes review:
`
`
`First Backup Counsel:
`Lead Counsel:
`
`Linnea Cipriano (Reg. No. 67,729)
`Goodwin Procter LLP
`620 Eighth Avenue
`INew York, NY 10018
`Phone: (212) 813-8800
`Fax: (212) 355-3333
`LCipriano@goodwinlaw.com
`
`IBackup Counsel:
`Backup Counsel:
`
`William G. James (Reg. No. 55,931)
`ALLEN & OVERY LLP
`1101 New York Ave, N.W.
`Washington, D.C. 20005
`Phone: (202) 683-3800
`william.james@allenovery.com
`
`Duncan Greenhalgh (Reg. No. 38,678)
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02210
`‘Phone: (617) 570-1000
`Fax: (617) 523-1231
`DGreenhalgh@goodwinlaw.com
`
`Joshua Weinger (Reg. No. 73,198)
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02210
`Phone: (617) 570-1000
`ax: (617) 523-1231
`JWeinger@goodwinlaw.com
`
`
`
`Elizabeth J. Holland (Reg. No. 47,657)
`LLEN & OVERY LLP
`221 Avenue of the Americas
`INew York, NY 10020
`IPhone: (212) 610-6300
`elizabeth.holland@allenovery.com
`
`Nicholas K. Mitrokostas (pro hac vice)
`ALLEN & OVERY LLP
`1 Beacon Street
`Boston, MA 02108
`Phone: (857) 353-4503
`nicholas.mitrokostas@allenovery.com
`“Backup Counsel:
`
`
`[Backup Counsel:
`
`
`
`_
`
`
`
`
`
`The individuals signing below have the authority to execute this document on
`
`U.S. Patent No. 9,220,631
`
`behalf of Patent Owner Novartis Technology LLC.
`
`Dated: March Q__, 2022
`
`
`
`Name:
`
`Title:
`
`
`
`U.S. Patent No. 9,220,631
`
`CERTIFICATE OF SERVICE
`
`A copyof this Patent Owner Novartis Technology LLC’s Updated Power
`
`of Attorney has been servedonPetitioner’s attorneys of record as followsvia
`
`electronic mail:
`
`Elizabeth Stotland Weiswasser
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8022
`F: 212-310-8007
`elizabeth.weiswasser@weil.com
`USPTO Reg. No. 55,721
`
`Anish R. Desai
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`anish.desai@weil.com
`USPTO Reg. No.73,760
`
`Natalie Kennedy
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`natalie.kennedy@weil.com
`USPTOReg. No. 68,511
`
`Andrew Gesior
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`andrew.gesior@weil.com
`
`
`
`U.S. Patent
`No. 9,220,631
`
`USPTO Reg. No. 76,588
`
`Christopher
`M. Pepe
`Weil, Gotshal
`& Manges LLP
`2001 M Street,
`N.W., Suite 600
`Washington,
`D.C. 20036
`T: 202-682-
`7000
`F: 202-857-0940
`christopher
`. pepe@weil.com
`USPTO Reg. No. 73,851
`
`Regeneron.lPR.
`Service@weil.com
`
`Petra Scamborova
`Regeneron
`Pharmaceuticals,
`Inc.
`777 Old Saw Mill River Road
`Tarrytown,
`NY 10591
`T: 914-847-7611
`petra.scamborova@regeneron.com
`Admitted
`pro hac
`vice
`
`James T. Evans
`Regeneron
`Pharmaceuticals,
`Inc.
`777 Old Saw Mill River Road
`Tarrytown,
`NY 10591
`T: 914-847-7000
`james.evans@regeneron.com
`USPTO Reg. No. 64,377
`
`Attorneys
`for Regeneron
`Pharmaceuticals,
`Inc.
`
`Dated: March 3
`, 2022 By: /Elizabeth
`J. Hollandi
`Elizabeth
`J. Holland
`(Reg. No. 47,657)
`ALLEN & OVERY LLP
`1221 A v
`enue of the Americas
`New York, NY 10020
`Tel: (212) 610-6300
`elizabeth.holland@allenovery.com
`
`Attorney
`for Patent
`Owners
`
`